Practical and Educational Challenges

From the Department of Pathology,* Brigham and Women’s Hospital, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Department of Pathology, University of North Carolina, Chapel Hill, North Carolina; Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; and Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

[1]  Mathew W. Wright,et al.  Guidelines for human gene nomenclature. , 2002, Genomics.

[2]  C. Boehm,et al.  ACMG recommendations for standards for interpretation of sequence variations , 2000 .

[3]  Shuji Ogino,et al.  Importance of standard nomenclature for SMN1 small intragenic (“subtle”) mutations , 2004, Human mutation.

[4]  M. Gleave,et al.  Inhibition of the phosphatidylinositol 3'-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells. , 2006, Cancer research.

[5]  Robert L Fine,et al.  Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143. , 2003, Cancer research.

[6]  R. Ramesh,et al.  Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. , 2005, Cancer research.

[7]  M. Stumvoll,et al.  Sex-specific effect of the Val1483Ile polymorphism in the fatty acid synthase gene (FAS) on body mass index and lipid profile in Caucasian children. , 2007 .

[8]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[9]  K. Klinger,et al.  Laboratory standards and guidelines for population-based cystic fibrosis carrier screening , 2001, Genetics in Medicine.

[10]  Sue Povey,et al.  Genew: the Human Gene Nomenclature Database, 2004 updates , 2004, Nucleic Acids Res..

[11]  Victoria M. Pratt,et al.  Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel , 2004, Genetics in Medicine.

[12]  S. Ogino,et al.  Spinal muscular atrophy: molecular genetics and diagnostics , 2004, Expert review of molecular diagnostics.

[13]  Ourania Horaitis,et al.  The challenge of documenting mutation across the genome: The human genome variation society approach , 2004, Human mutation.

[14]  J. D. den Dunnen,et al.  Standardizing mutation nomenclature: Why bother? , 2003, Human mutation.

[15]  Sue Povey,et al.  Genew: the Human Gene Nomenclature Database , 2002, Nucleic Acids Res..

[16]  Martijn J. Schuemie,et al.  Thesaurus-based disambiguation of gene symbols , 2005, BMC Bioinformatics.

[17]  S. Antonarakis.  Recommendations for a nomenclature system for human gene mutations , 1998 .

[18]  S. Povey,et al.  The changing challenges of nomenclature , 1999, Cytogenetic and Genome Research.